Category: Drug Development
Drug Development market research reports by Frost & Sullivan
-
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services M&As, Partnerships, and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023 ... Read More
-
Innovations in Small Molecule Drug Delivery and Formulation
Innovations in Small Molecule Drug Delivery and Formulation Disruptive Technologies Drive Growth Opportunities for New Product Launches Small molecules, which are the leading drug class across indications, face several issues that threaten their drug delivery efficacy. They suffer from off-target ef ... Read More
-
Top 5 Growth Opportunities for the Pharmaceutical Industry, 2024
Top 5 Growth Opportunities for the Pharmaceutical Industry, 2024 In 2024, the life science (LS) industry’s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Par ... Read More
-
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023 More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid- ... Read More
-
Growth Opportunities of Generative AI For Healthcare
Growth Opportunities of Generative AI For Healthcare The application of Generative AI (Gen AI) in healthcare is a rapidly growing field. In recent years, emerging applications in drug discovery and development, medical imaging analysis, digital twins, synthetic data, and electronic health records ma ... Read More
-
Generative Artificial Intelligence Growth Opportunities in the Healthcare and Life Science Industry
Generative Artificial Intelligence Growth Opportunities in the Healthcare and Life Science Industry Possibilities Exist to Adapt Large Language Models and Reinvent Enterprise Functions This project provides an overview of the effects of generative AI (Gen AI) on the healthcare and life science indus ... Read More
-
Growth Opportunities in the Laboratory Automation Market
Growth Opportunities in the Laboratory Automation Market Automated Liquid Handlers and Laboratory Information Management Systems (LIMS) Enable Market Expansion The laboratory automation market refers to the use of various technologies, software, and equipment to automate laboratory processes and wor ... Read More
-
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities Right Shoring and Targeted Therapeutics Create Future Growth CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecul ... Read More
-
Emerging Landscape of Targeted Protein Degradation Therapeutics
Emerging Landscape of Targeted Protein Degradation Therapeutics Rapid Technology Advances Bolster a Robust Therapeutic Pipeline This Frost & Sullivan research report provides an in-depth analysis of the emerging targeted protein degradation (TPD) space. TPD strategies enable treating various disease ... Read More
-
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics Disruptive Technology Advances in SynBio Foster a Thriving Stakeholder Ecosystem and Accelerate Biopharma Developments The SynBio field has evolved well over the past two decades, with significant technology disruptions le ... Read More
-
Growth Indicators for Technology-enabled Drug Discovery
Growth Indicators for Technology-enabled Drug Discovery Innovative Business Models across the TEDD Landscape Support the Emergence of AI-powered Therapeutics Providers As the industry continues its innovation spree across novel small and large molecule therapies, such as RNA targeted small molecules ... Read More
-
Technology Advances in Senolytics
Technology Advances in Senolytics Innovative Drug Development Culture Working to Prolong Health Spans and Eliminate Aging Cells Senolytics is a relatively new field of development that falls under the broad category of senotherapeutics, along with senomorphics and senostatics. Although nascent, the ... Read More
-
Antibody-drug Conjugates: Technology Growth Opportunities
Antibody-drug Conjugates: Technology Growth Opportunities Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agen ... Read More
-
Global Contract Research Organization (CRO) Growth Opportunities
Global Contract Research Organization (CRO) Growth Opportunities The COVID-19 pandemic led to a sudden surge in R&D activities across the world. Both small and large pharmaceutical and biotech companies were engaged in tremendous efforts to either develop new molecules or repurpose existing therapie ... Read More
-
Developments in Digital Biomanufacturing: Technology Growth Opportunities
Developments in Digital Biomanufacturing: Technology Growth Opportunities Digitalization of the entire value chain will drive next-generation biomanufacturing. The industry is all set to move away from the traditional pen-and-paper-based process to a more advanced, digitized, track-and-trace process ... Read More
-
Global Bioanalytical Testing Services, 2021–2027
Global Bioanalytical Testing Services, 2021–2027 As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract deve ... Read More
-
Growth Opportunities for Digital Biomarkers in Drug Development
Growth Opportunities for Digital Biomarkers in Drug Development Pharmaceutical companies spend billions of dollars in drug development because of expensive and time-consuming clinical trials, with a meager success rate. Frequent clinical visits, manual data processing, and a lack of consistent data ... Read More
-
Growth Opportunities in AI for Drug Target Discovery and Validation
Growth Opportunities in AI for Drug Target Discovery and Validation A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unex ... Read More
-
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022 Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the i ... Read More
-
Global Vaccine Growth Opportunities
Global Vaccine Growth Opportunities Frost & Sullivan provides an outlook for the global vaccine industry for 2022 and beyond, including emerging trends and growth opportunities. Innovation, which remains mainstream in vaccine development, is augmenting investments by emerging vaccine developers in d ... Read More
-
Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities
Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug developmen ... Read More
Research Assistance
